ZW14480A1 - Pharmaceutical ethers preparation use and intermediates therefore and their preparation - Google Patents

Pharmaceutical ethers preparation use and intermediates therefore and their preparation

Info

Publication number
ZW14480A1
ZW14480A1 ZW144/80A ZW14480A ZW14480A1 ZW 14480 A1 ZW14480 A1 ZW 14480A1 ZW 144/80 A ZW144/80 A ZW 144/80A ZW 14480 A ZW14480 A ZW 14480A ZW 14480 A1 ZW14480 A1 ZW 14480A1
Authority
ZW
Zimbabwe
Prior art keywords
preparation
intermediates
pharmaceutical
ethers
preparation use
Prior art date
Application number
ZW144/80A
Other languages
English (en)
Inventor
Geoffrey Kneen
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZW14480A1 publication Critical patent/ZW14480A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/74Unsaturated compounds containing —CHO groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZW144/80A 1979-06-29 1980-06-27 Pharmaceutical ethers preparation use and intermediates therefore and their preparation ZW14480A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922781 1979-06-29

Publications (1)

Publication Number Publication Date
ZW14480A1 true ZW14480A1 (en) 1982-03-17

Family

ID=10506199

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW144/80A ZW14480A1 (en) 1979-06-29 1980-06-27 Pharmaceutical ethers preparation use and intermediates therefore and their preparation

Country Status (18)

Country Link
US (1) US4410537A (xx)
EP (1) EP0022229B1 (xx)
JP (1) JPS5649335A (xx)
KR (2) KR850000073B1 (xx)
AU (1) AU545274B2 (xx)
DE (1) DE3061269D1 (xx)
DK (1) DK159770C (xx)
FI (1) FI71929C (xx)
GB (1) GB2053218B (xx)
GR (1) GR68748B (xx)
HU (1) HU190774B (xx)
IL (1) IL60422A (xx)
IT (1) IT1133025B (xx)
MW (1) MW2380A1 (xx)
OA (1) OA06699A (xx)
ZA (1) ZA803880B (xx)
ZM (1) ZM5780A1 (xx)
ZW (1) ZW14480A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI72510C (fi) * 1980-12-18 1987-06-08 Wellcome Found Foerfarande foer framstaellning av terapeutiskt anvaendbara eterfoereningar.
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
AU6019898A (en) 1997-01-09 1998-08-03 Cohesion Technologies, Inc. Devices for tissue repair and methods for preparation and use thereof
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
NZ530450A (en) * 1999-11-05 2004-06-25 Emisphere Tech Inc Phenoxy carboxylic acid compounds and compositions for delivering active agents
WO2001070663A2 (en) * 2000-03-17 2001-09-27 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
SG10202009963PA (en) 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use
CN104135859B (zh) 2011-12-28 2017-06-27 全球血液疗法公司 取代的苯甲醛化合物及其用于增加组织氧合的方法
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (es) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MY183637A (en) 2013-03-15 2021-03-04 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AP2015008721A0 (en) * 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
EP3036222A2 (en) * 2013-08-23 2016-06-29 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PT3102208T (pt) 2014-02-07 2021-04-05 Global Blood Therapeutics Inc Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído
BR112017018954A2 (pt) 2015-03-06 2018-05-15 Beyondspring Pharmaceuticals, Inc. uso de forma mutante de proteína ras e método para tratar câncer
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
IL260933B2 (en) * 2016-02-08 2023-04-01 Beyondspring Pharmaceuticals Inc Preparations containing tocorsol or its analogues
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11401241B2 (en) * 2018-03-22 2022-08-02 Virginia Commonwealth University Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin
KR20210093990A (ko) 2018-11-19 2021-07-28 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈을 조정할 수 있는 2-포르밀-3-히드록시페닐옥시메틸 화합물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL236575A (xx) * 1958-04-30
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
DE2209128C3 (de) 1971-03-05 1981-10-22 CIBA-GEIGY AG, 4002 Basel Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller
CH550776A (de) 1971-03-05 1974-06-28 Ciba Geigy Ag Herstellung neuer bis-stilbenverbindungen.
GB1511645A (en) 1974-05-31 1978-05-24 Univ Ife Sickle cell anaemia treatment
US4137309A (en) * 1976-10-14 1979-01-30 The Procter & Gamble Company Therapeutic treatment

Also Published As

Publication number Publication date
GR68748B (xx) 1982-02-16
ZA803880B (en) 1982-02-24
DK159770C (da) 1991-04-22
KR850000073B1 (ko) 1985-02-18
IT1133025B (it) 1986-07-09
JPS5649335A (en) 1981-05-02
MW2380A1 (en) 1982-03-10
EP0022229B1 (en) 1982-12-08
EP0022229A1 (en) 1981-01-14
AU545274B2 (en) 1985-07-11
US4410537A (en) 1983-10-18
IT8049108A0 (it) 1980-06-27
FI802052A (fi) 1980-12-30
IL60422A (en) 1984-06-29
FI71929C (fi) 1987-03-09
KR830002693A (ko) 1983-05-30
DE3061269D1 (en) 1983-01-13
KR850000072B1 (ko) 1985-02-18
HU190774B (en) 1986-11-28
AU5969780A (en) 1981-01-08
DK159770B (da) 1990-12-03
FI71929B (fi) 1986-11-28
KR840004668A (ko) 1984-10-22
OA06699A (fr) 1982-05-31
IL60422A0 (en) 1980-09-16
ZM5780A1 (en) 1983-11-21
DK279780A (da) 1980-12-30
GB2053218A (en) 1981-02-04
GB2053218B (en) 1984-01-25
JPH0154339B2 (xx) 1989-11-17

Similar Documents

Publication Publication Date Title
ZW14480A1 (en) Pharmaceutical ethers preparation use and intermediates therefore and their preparation
GB2055800B (en) Guanidinothiazoles and their preparation and use
ZA818741B (en) Pharmaceutical compounds,preparation,use and intermediates therefor and their preparation
ZA803567B (en) Pharmaceutical preparations
GB2065122B (en) Basic ethers their preparation and pharmaceutical compositions containing the same
DE3064823D1 (en) Pyridyl-2-oxy-phenyloxime ethers and esters, their preparation and their use as herbicides
IL60874A (en) Preparation of 4-fluoro-3-phenoxy-benzaldehyde,intermediates therefor and their preparation
NZ191709A (en) Naphtylmethyl-piperidines and pharmaceutical compostions intermediates
ZW12380A1 (en) Novel 3-vinyl-cephalosporins and their preparation
ZA804196B (en) Pharmaceutical formulations
JPS565207A (en) Tireeliner and its preparation
GB2051062B (en) 3-vinyl-cephalosporin derivatives and their preparation
JPS5422497A (en) Novel polyether compound* preparation thereof and use as pharmaceutical
GB2051794B (en) Hydroxyamino-eburnane derivatives their preparation and use pharmalceutical compositions containing them and intermediates therefor
GB2010806A (en) Pyrindines and their preparation formulations and use
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
DE3064789D1 (en) New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
DE3071198D1 (en) Acridinones, their preparation and use; intermediates and their preparation
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
NZ192886A (en) Preparation of 7-acylindolin-2-ones and intermediates therein
DE3060100D1 (en) Omega-halogeno-acetophenone oxime ethers, preparation thereof and their use as intermediates in the preparation of omega-azolyl-acetophenone oxime ethers
ZW11780A1 (en) Novel pesticides preparation and use
EP0044954A3 (en) Anthracyclinglycosides, their preparation and intermediates, and pharmaceutical preparations
GB2009739B (en) A-40104 antibiotics their preparation use and formulations containing them
DE2962784D1 (en) Isoquinoline compounds, their preparation, pharmaceutical formulations containing them and intermediates